Literature DB >> 30722961

Similarities and differences in antimicrobial prescribing between major city hospitals and regional and remote hospitals in Australia.

Jaclyn L Bishop1, Thomas R Schulz2, David C M Kong3, Rodney James4, Kirsty L Buising5.   

Abstract

Many regional and remote hospitals (RRHs) do not have the specialist services that usually support antimicrobial stewardship (AMS) programmes in major city hospitals. It is not known if this is associated with higher rates of inappropriate antimicrobial prescribing. The aim of this study was to identify similarities and differences in antimicrobial prescribing patterns between major city hospitals and RRHs in Australia. The Australian Hospital National Antimicrobial Prescribing Survey (H-NAPS) datasets from 2014, 2015 and 2016 (totalling 47,876 antimicrobial prescriptions) were analysed. The antimicrobial prescribed, indications for use, documentation of indication, recording of a review date and assessment of the appropriateness of prescribing were evaluated. Overall, inappropriate prescribing of antimicrobials was higher in RRHs than in major city hospitals (24.0% vs. 22.1%; P<0.001). Compared with major city hospitals, inappropriate prescribing of ceftriaxone was higher in RRHs (33.9% vs. 27.6%; P<0.001), as was inappropriate prescribing for cellulitis (25.7% vs. 19.0%; P≤0.001). A higher rate of inappropriate prescribing was noted for some high-risk infections in RRHs compared with major city hospitals, including Gram-positive bacteraemia with sepsis (12.6% vs. 6.5%; P=0.004), empiric therapy for sepsis (26.0% vs. 12.0%; P<0.001) and endocarditis (8.2% vs. 2.7%; P=0.02). To the authors' knowledge, this is the largest study to date comparing antimicrobial prescribing of RRHs with major city hospitals. A key finding was that antimicrobial prescribing was more frequently inappropriate for some high-risk infections treated in RRHs. Targeted strategies that support appropriate antimicrobial prescribing in RRHs are required.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Antimicrobial; Appropriateness; Hospital; Rural; Stewardship

Mesh:

Substances:

Year:  2018        PMID: 30722961     DOI: 10.1016/j.ijantimicag.2018.10.009

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  5 in total

1.  Antimicrobial stewardship in remote primary healthcare across northern Australia.

Authors:  Will Cuningham; Lorraine Anderson; Asha C Bowen; Kirsty Buising; Christine Connors; Kathryn Daveson; Joanna Martin; Stacey McNamara; Bhavini Patel; Rodney James; John Shanks; Kerr Wright; Trent Yarwood; Steven Yc Tong; Jodie McVernon
Journal:  PeerJ       Date:  2020-07-22       Impact factor: 2.984

2.  Rural-urban differences in antibiotic prescribing for uncomplicated urinary tract infection.

Authors:  Abbye W Clark; Michael J Durkin; Margaret A Olsen; Matthew Keller; Yinjiao Ma; Caroline A O'Neil; Anne M Butler
Journal:  Infect Control Hosp Epidemiol       Date:  2021-02-24       Impact factor: 3.254

Review 3.  The feasibility and generalizability of assessing the appropriateness of antimicrobial prescribing in hospitals: a review of the Australian National Antimicrobial Prescribing Survey.

Authors:  Rodney James; Yoshiko Nakamachi; Andrew Morris; Miranda So; Sasheela Sri La Sri Ponnampalavanar; Pem Chuki; Ly Sia Loong; Pauline Siew Mei Lai; Caroline Chen; Robyn Ingram; Arjun Rajkhowa; Kirsty Buising; Karin Thursky
Journal:  JAC Antimicrob Resist       Date:  2022-02-09

4.  Factors associated with antimicrobial choice for surgical prophylaxis in Australia.

Authors:  Courtney Ierano; Karin Thursky; Trisha Peel; Sonia Koning; Rod James; Sandra Johnson; Lisa Hall; Leon J Worth; Caroline Marshall
Journal:  JAC Antimicrob Resist       Date:  2020-07-18

5.  Geospatial epidemiology of Staphylococcus aureus in a tropical setting: an enabling digital surveillance platform.

Authors:  T M Wozniak; W Cuningham; S Buchanan; S Coulter; R W Baird; G R Nimmo; C C Blyth; S Y C Tong; B J Currie; A P Ralph
Journal:  Sci Rep       Date:  2020-08-05       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.